AusPAR: Bevacizumab

Australian Public Assessment Report

AusPAR

AusPAR: Bevacizumab [PDF, 471.86 KB]

AusPAR: Bevacizumab [Word, 534.82 KB]

Attachment: Product Information for Bevacizumab [PDF, 696.78 KB]

Attachment: Product Information for Bevacizumab [Word, 474.03 KB]

Device/Product Name

Zirabev

Active ingredients

Bevacizumab

AusPAR Date

26 February 2020

Published

11 March 2020

Submission Number

PM-2018-03842-1-4

Submission Type

New biosimilar medicine

Decision

Approved